top of page
Search Results

215 items found for "Bcl-2"

  • GPCR Retreat Registration 2023 | Dr. GPCR Ecosystem

    Registration If you attend the GPCR Retreat, click here

  • Ep 22 with Dr. Kari Johnson

    Dr. GPCR Podcast << Back to podcast list Dr. Kari Johnson About this episode Dr. Kari Johnson is currently an assistant professor at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. She is a neuropharmacologist with an interest in the long-term effects of alcohol abuse on neural circuits. Kari completed her Ph.D. in Pharmacology at Vanderbilt University before continuing her training as a postdoctoral fellow at the Vanderbilt Center for Neuroscience Drug Discovery, the National Institute of General Medical Sciences, and the National Institute on Alcohol Abuse and Alcoholism. All through her career, the recurring theme in Kari’s work has been GPCRs and more specifically Metabotropic Glutamate Receptors. Join me and learn more about how Kari studies GPCRs in basal ganglia circuits following chronic alcohol exposure in mice. Dr. Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand your needs to bring you exciting and informative content; this short survey should take 5 minutes to fill. Listen and subscribe to where you get your podcasts. << Previous Podcast Episode Next Podcast Episode >>

  • Adhesion GPCR Workshop 2024 Organizers

    Meet the Organizers behind the AGPCR24 Antony Boucard Jr, PhD Host and Organizer Cinvestav, Mexico City Yamina Berchiche, PhD Co-organizer Dr. GPCR, Boston Andreína Martín Website & Social Media Coordinator Dr. GPCR, Boston Ivanna Rey Executive Assistant Dr. GPCR, Boston

  • Ep 20 with Dr. Jennifer Pluznick

    Dr. GPCR Podcast << Back to podcast list Dr. Jennifer Pluznick About this episode Dr. Pluznick discovered that olfactory receptors in mice are also expressed in their kidneys and blood vessels. Her research is focused on the role of chemosensory GPCRs in regulating renal and cardiovascular function, and identifying renal/cardiovascular olfactory receptor ligands, and relating them to whole-animal physiology. This work contributes to a better understanding of how the kidney helps maintain homeostasis in humans. Jennifer is currently an assistant professor of physiology at the Johns Hopkins School of Medicine. She received her undergraduate degree in biology from Truman State University and earned her Ph.D. in renal physiology from the University of Nebraska Medical Center. She then spent five years training as a postdoctoral fellow in the laboratory of Michael Caplan at Yale University, where she studied both renal physiology and sensory biology systems and focused on olfaction. Dr. Jennifer Pluznick on the web John Hopkins Pluznick Lab Pubmed Ted Talk Dr. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand your needs to bring you exciting and informative content; this short survey should take 5 minutes to fill. Listen and subscribe to where you get your podcasts. << Previous Podcast Episode Next Podcast Episode >>

  • Ep 23 with Dr. Qing Fan

    Dr. GPCR Podcast << Back to podcast list Dr. Qing Fan About this episode Dr. Fan is currently an associate professor of Pharmacology and Pathology and Cell Biology at Columbia University in NYC. Qing is a structural biologist interested in the molecular mechanisms controlling how class C GPCRs transmit signals. She obtained her bachelor's, master and doctoral degrees at Harvard University and completed her postdoctoral training with Dr. Hendrickson at Columbia University. Join us and learn more about Qing's work and how we powered through a technical issue during the interview. Dr. Qing Fan on the web Fan Lab Dr. Fan at Columbia University Research Gate LinkedIn Pubmed Dr. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand your needs to bring you exciting and informative content; this short survey should take 5 minutes to fill. Listen and subscribe to where you get your podcasts. << Previous Podcast Episode Next Podcast Episode >>

  • Terms and Conditions | Dr. GPCR Ecosystem

    forth herein, please exit our website immediately and do not use access and/or browse it further. ​ 2. and shall not affect the validity and enforceability of the remaining provisions of the agreement. ​ 20

  • Suppor Dr. GPCR Ecosystem

    Frequency One time One time Monthly Monthly Amount $5.00 $5.00 $25.00 $25.00 $100.00 $100.00 $250.00 $250.00 Other Other 0/300 Comment (optional) Donate

  • Elucidation of active components and target mechanism in Jinqiancao granules for the treatment of prostatitis and benign prostatic hyperplasia

    Jinqiancao granules for the treatment of prostatitis and benign prostatic hyperplasia Published date June 28 , 2024 Abstract " Ethnopharmacological relevance: Prostatitis and benign prostatic hyperplasia (BPH) compounds showed potent GPR35 agonistic activity (EC50 < 10 μM) and the GPR35 agonism action of PAL-21

  • Ep 95 with Chris Langmead

    ., a UK-based biotechnology company (2009-2012), where he was responsible all of the company’s discovery successes enabled the US$400M sale of Heptares Therapeutics Ltd. to the Sosei Group Corporation in 2015 Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). respectively, was the youngest person to be elected as a Fellow of the British Pharmacological Society in 2012 , and was the recipient of the British Pharmacological Society Novartis Prize in 2017.

  • Structure-based discovery of functionally selective 5-HT1A receptor agonists

    Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec 22nd

  • Coffee Break 4

    Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec 22nd

  • Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration

    histamine receptor H1 enhances calcium signaling and cancer cell migration Published date February 1, 2023 Simultaneous activation of CXCR4 and HRH1 synergistically increases calcium flux in MDA-MB-231 cells Costimulation of CXCR4 and HRH1 also significantly enhances CXCL12-induced MDA-MB-231 cell migration,

  • Registration

    Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Registration Date & Time Thursday, November 2nd / 11:00 AM - 1:30 PM Previous Event Next Event Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec 22nd

  • Dinner 1

    Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Dinner 1 Date & Time Thursday, November 2nd / 8:00 PM Previous Event Next Event Great Lakes Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec 22nd

  • Ep 126 with Dr. Françoise Bachelerie

    FB’ team has identified the orphan CXCR7/ACKR3 receptor as being the 2nd receptor for CXCL12, which behaves

  • Ep 44 with Dr. Steven Foord

    Foord trained as a Physiologist and Pharmacologist and worked for Glaxo through to GSK from 1986 to 2008

  • Ep 51 with Dr. Mark Connor

    Grant-funded independent research positions from 2001 at University of Sydney (opioids and sensory neurons (more opioids, cannabinoids and T-type Ca channels) and Brain and Mind Research Institute (Sydney). 2009

  • Ep 49 with Dr. Sudha Shenoy

    Lefkowitz (Nobel Laureate, 2012) at Duke University. Dr.

  • Ep 84 with Rosie Dawaliby

    a Ph.D. in Life Sciences from the University of Lausanne, Switzerland, Department of Biochemistry (2005 -2009), where I started working on membranes and membrane protein biochemistry by studying membrane fusion -2015). In 2016, I joined a company that specialized in therapeutic candidate discovery targeting GPCR ( Confo Before founding G.CLIPS biotech in June 2020.

  • Ep 131 with Dr. Richard Premont

    1999, obtained an independent faculty position at Duke in Gastroenterology, where he remained until 2018 In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies

  • Ep 105 with Annabelle Milner

    She presented her Ph.D. work at the Society of Endocrinology Conference 2022 and was awarded the best

  • Ep 14 with Dr. Bryan Roth

    Bryan leads a $26.9 Million project to create better psychiatric medications, among other things. Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project

  • Ep 147 with Dr. Demet Araç

    She moved to the University of Texas Southwestern Medical Center at Dallas in 2000 to work with Dr. In 2013, Demet began her independent research career at the University of Chicago within the Department Demet explained that since the year 2000, the field has seen significant growth, with important discoveries Demet shared that they have been working on the Latrophilin project since 2013, screening about 20 adhesion

  • Interaction with the cell adhesion molecule NEGR1 affects mGluR5 cell signalling

    Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to She obtained her Ph.D. from UFMG in 2006 and, after that, she performed her postdoctorate studies at She returned to Brazil in 2010, when she founded her independent research group. Since then, Dr. Ribeiro H factor is 28, according to Web of Science, and she is an affiliated member of the Brazilian Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec 22nd

  • Ep 97 with Robert Laprairie

    He was the 2018 and 2021 recipient of the Young Investigator of the Year Awards from the British Pharmacological In 2019 he became the Director of Education for the Canadian Consortium for the Investigation of Cannabinoids

  • Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19

    protease-activated receptor 1 autoantibodies are associated with severe COVID-19 Published date December 27 , 2022 Abstract In patients with severe #COVID19, increased levels of autoantibodies against PAR1 were

bottom of page